Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows Post author: Post published:June 4, 2024 Post category:uncategorized Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells. You Might Also Like High-income earners have 32% lower stroke mortality risk May 28, 2024 Study exposes food insecurity among graduate students and postdocs February 21, 2024 Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease July 8, 2024
Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease July 8, 2024